152 related articles for article (PubMed ID: 11319229)
1. Regulation of plasmin-dependent fibrin clot lysis by annexin II heterotetramer.
Choi KS; Fitzpatrick SL; Filipenko NR; Fogg DK; Kassam G; Magliocco AM; Waisman DM
J Biol Chem; 2001 Jul; 276(27):25212-21. PubMed ID: 11319229
[TBL] [Abstract][Full Text] [Related]
2. Annexin II tetramer inhibits plasmin-dependent fibrinolysis.
Choi KS; Ghuman J; Kassam G; Kang HM; Fitzpatrick SL; Waisman DM
Biochemistry; 1998 Jan; 37(2):648-55. PubMed ID: 9425087
[TBL] [Abstract][Full Text] [Related]
3. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin.
MacLeod TJ; Kwon M; Filipenko NR; Waisman DM
J Biol Chem; 2003 Jul; 278(28):25577-84. PubMed ID: 12730231
[TBL] [Abstract][Full Text] [Related]
4. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation.
Kassam G; Le BH; Choi KS; Kang HM; Fitzpatrick SL; Louie P; Waisman DM
Biochemistry; 1998 Dec; 37(48):16958-66. PubMed ID: 9836589
[TBL] [Abstract][Full Text] [Related]
5. The p11 subunit of annexin II heterotetramer is regulated by basic carboxypeptidase.
Fogg DK; Bridges DE; Cheung KK; Kassam G; Filipenko NR; Choi KS; Fitzpatrick SL; Nesheim M; Waisman DM
Biochemistry; 2002 Apr; 41(15):4953-61. PubMed ID: 11939791
[TBL] [Abstract][Full Text] [Related]
6. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
Kwon M; MacLeod TJ; Zhang Y; Waisman DM
Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
[TBL] [Abstract][Full Text] [Related]
7. Regulation of plasmin activity by annexin II tetramer.
Fitzpatrick SL; Kassam G; Choi KS; Kang HM; Fogg DK; Waisman DM
Biochemistry; 2000 Feb; 39(5):1021-8. PubMed ID: 10653646
[TBL] [Abstract][Full Text] [Related]
8. Identification of annexin II heterotetramer as a plasmin reductase.
Kwon M; Caplan JF; Filipenko NR; Choi KS; Fitzpatrick SL; Zhang L; Waisman DM
J Biol Chem; 2002 Mar; 277(13):10903-11. PubMed ID: 11781322
[TBL] [Abstract][Full Text] [Related]
9. Role of annexin II tetramer in plasminogen activation.
Kang HM; Choi KS; Kassam G; Fitzpatrick SL; Kwon M; Waisman DM
Trends Cardiovasc Med; 1999; 9(3-4):92-102. PubMed ID: 10578524
[TBL] [Abstract][Full Text] [Related]
10. The role of the annexin A2 heterotetramer in vascular fibrinolysis.
Madureira PA; Surette AP; Phipps KD; Taboski MA; Miller VA; Waisman DM
Blood; 2011 Nov; 118(18):4789-97. PubMed ID: 21908427
[TBL] [Abstract][Full Text] [Related]
11. A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis.
Schneider M; Nesheim M
J Biol Chem; 2004 Apr; 279(14):13333-9. PubMed ID: 14715655
[TBL] [Abstract][Full Text] [Related]
12. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
[TBL] [Abstract][Full Text] [Related]
13. Interactions between staphylokinase, plasmin(ogen), and fibrin. Staphylokinase discriminates between free plasminogen and plasminogen bound to partially degraded fibrin.
Sakharov DV; Lijnen HR; Rijken DC
J Biol Chem; 1996 Nov; 271(44):27912-8. PubMed ID: 8910391
[TBL] [Abstract][Full Text] [Related]
14. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
[TBL] [Abstract][Full Text] [Related]
15. Annexin A2-S100A10 heterotetramer, a novel substrate of thioredoxin.
Kwon M; Yoon CS; Jeong W; Rhee SG; Waisman DM
J Biol Chem; 2005 Jun; 280(25):23584-92. PubMed ID: 15849182
[TBL] [Abstract][Full Text] [Related]
16. Herpesviruses enhance fibrin clot lysis.
Gershom ES; Vanden Hoek AL; Meixner SC; Sutherland MR; Pryzdial EL
Thromb Haemost; 2012 Apr; 107(4):760-8. PubMed ID: 22318336
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
Lobov S; Croucher DR; Saunders DN; Ranson M
Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
[TBL] [Abstract][Full Text] [Related]
18. The role of annexin II tetramer in the activation of plasminogen.
Kassam G; Choi KS; Ghuman J; Kang HM; Fitzpatrick SL; Zackson T; Zackson S; Toba M; Shinomiya A; Waisman DM
J Biol Chem; 1998 Feb; 273(8):4790-9. PubMed ID: 9468544
[TBL] [Abstract][Full Text] [Related]
19. The effect of plasmin-mediated degradation on fibrinolysis and tissue plasminogen activator diffusion.
Bannish BE; Paynter B; Risman RA; Shroff M; Tutwiler V
Biophys J; 2024 Mar; 123(5):610-621. PubMed ID: 38356261
[TBL] [Abstract][Full Text] [Related]
20. [The effect of heparin on the proteolytic and fibrinolytic activity on plasmin(ogen) and fibrin clot lysis].
Kudinov SA; Kolesnik LA; Makogonenko EM; Shuliakovskaia TA
Biokhimiia; 1989 Nov; 54(11):1881-7. PubMed ID: 2534055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
